×
Seguir
Destacado

Oncostellae

Startup

Biotech startup

SECTORES

WEB OFICIAL

Sobre Oncostellae

Oncostellae is a biotech startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases. The company was founded in 2013 by a team of medicinal chemists and pharmacologists with a common track record in drug discovery who bring together the experience and network of collaborators to develop clinical candidates from their conception until Phase I/II. Further development and commercialization rights will be licensed to consolidated pharmaceutical companies. In 2014 Guido Kurz, a seasoned research manager with international trajectory in various pharmaceutical and biotech companies (including Pharmacia Corp. and Oryzon Genomics), joined Oncostellae as CEO of the company.

Galería Oncostellae 0

Oncostellae no tiene ninguna imágen en su galería.

Datos Oncostellae

Oficinas
Localizaciones
Total inversión 1.520.000€
Rondas inversión
  • Early/Startup
    250,00 K€

Equipo Oncostellae 0

Oncostellae no tiene a su equipo agregado

Inversores Oncostellae 2

Acceleradoras Oncostellae 0

Oncostellae no ha pasado por aceleradoras

Noticias Oncostellae 1

Política de Cookies Utilizamos cookies propias y de terceros para mejorar nuestros servicios y la experiencia de usuario. Si continúa navegando, consideramos que acepta su uso.

Aceptar